Posted by Michael Wonder on 21 Oct 2025
Glaukos announces FDA approval of Epioxa
20 October 2025 - Epioxa expected to be commercially available in Q1, 2026.
Glaukos Corporation announced today the US FDA approved its Epioxa HD new drug application.
20 October 2025 - Epioxa expected to be commercially available in Q1, 2026.
Glaukos Corporation announced today the US FDA approved its Epioxa HD new drug application.